The Controversy Over Zantac and Cancer Risks

In 2019, the heartburn drug Zantac was found to contain high levels of a probable carcinogen. Glaxo says the medication, which is also known as ranitidine, doesn’t cause tumors, but the company was warned by its own scientists and independent researchers about the potential danger.